You are here: Industry Insights > Astrea Bioseparations

News List

Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and Singapore PharmaSources.com
September 18, 2021
Cambridge, UK – September 16, 2021 – Astrea Bioseparations, a leading provider of bioseparations products and services, today announced two new investments to enhance operations and customer support resources.
Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology PharmaSources.com
December 21, 2020
MENLO PARK, California and CAMBRIDGE, United Kingdom, December 21, 2020 – Gamma Biosciences, a life sciences tools platform created by KKR, today announced a licensing.
Astrea Bioseparations, Thermo Fisher Scientific Sign Supply Agreement for Pre-Packed Bioseparation Columns americanpharmaceuticalreview
March 13, 2020
Astrea Bioseparations, formerly Prometic Bioseparations, has entered into a non-exclusive supply agreement with Thermo Fisher Scientific to manufacture pre-packed EvolveD™ columns ...